Dexlansoprazole (Dexilant) is contraindicated in patients with known hypersensitivity to any component of the formulation [see Description]. Hypersensitivity reactions, may include anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute tubulointerstitial nephritis and urticaria [see Precautions and Adverse Reactions].
PPIs, including Dexlansoprazole (Dexilant), are contraindicated with rilpivirine-containing products [see Interactions].